Histological heterogeneity of Ewing's sarcoma/PNET: An immunohistochemical analysis of 415 genetically confirmed cases with clinical support

Virchows Archiv

Volumn 455, Issue 5, 2009, Pages 397-411

  Llombart Bosch, Antonio ^a   Machado, Isidro ^a   Navarro, Samuel ^a   Bertoni, Franco ^b   Bacchini, Patrizia ^b   Alberghini, Marco ^b   Karzeladze, Apollon ^c   Savelov, Nikita ^c   Petrov, Semyon ^d   Alvarado Cabrero, Isabel ^e   Mihaila, Doina ^f   Terrier, Philippe ^g   Lopez Guerrero, Jose Antonio ^h   Picci, Piero ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d Cancer Oncology Center   (Russian Federation)

^e HOSPITAL GENERAL DE MÉXICO   (Mexico)

^f Children's Hospital   (Romania)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

ESFT; Histopathology; Immunohistochemistry

Indexed keywords

ANTIBODY; CD99 ANTIGEN; PROTEIN HNK1; TRANSCRIPTION FACTOR FLI 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE FREE SURVIVAL; EWING SARCOMA; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD57; BONE NEOPLASMS; CAVEOLIN 1; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; PROGNOSIS; PROTO-ONCOGENE PROTEIN C-FLI-1; SARCOMA, EWING'S; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 73349083916     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0842-7     Document Type: Article

References (98)

1. Dahlin D (1978) Bone tumors: general aspects and data on 6,221 cases, 3rd edn. Thomas, Springfield, pp 274-287
2. Dorfman HD, Czerniak B (1998) Bone tumors. Mosby, St. Louis, pp 607-663
3. J Ewing 1921 Diffuse endothelioma of bone Proc NY Soc Pathol 21 17 24
4. LP Dehner 1993 Primitive neuroectodermal tumor and Ewing's sarcoma Am J Surg Pathol 17 1 13
5. R Jaffe M Santamaria EJ Yunis, et al. 1984 The neuroectodermal tumor of bone Am J Surg Pathol 8 885 898
6. MW Verrill IR Judson CL Harmer, et al. 1997 Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? J Clin Oncol 15 2611 2621
7. Ushigome S, Machinami R, Sorensen PH (2002) Ewing sarcoma/primitive neuroectodermal tumour (PNET). In: Fletcher CDM, Mertens F (eds) Classification of tumours pathology and genetic of tumours of soft tissue and bone. World Health Organization, Geneva, pp 298-300
8. FB Askin J Rosai RK Sibley, et al. 1979 Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis Cancer 43 2438 2451
9. M Fukunaga S Ushigome 1998 Periosteal Ewing-like adamantinoma Virchows Arch 433 385 389
10. A Llombart-Bosch R Blache A Peydro-Olaya 1978 Ultrastructural study of 28 cases of Ewing's sarcoma: typical and atypical forms Cancer 41 1362 1373
11. P Meister E Konrad G Hubner 1979 Malignant tumor of humerus with features of "adamantinoma" and Ewing's sarcoma Pathol Res Pract 166 112 122
12. AG Nascimento KK Unii DJ Pritchard, et al. 1980 A clinicopathologic study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone Am J Surg Pathol 4 29 36
13. S Navarro R Noguera A Pellin, et al. 2002 Atypical pleomorphic extraosseous Ewing tumor/peripheral primitive neuroectodermal tumor with unusual phenotypic/genotypic profile Diagn Mol Pathol 11 9 15
14. G Maeda F Masui R Yokoyama, et al. 1998 Ganglion cells in Ewing's sarcoma following chemotherapy: a case report Pathol Int 48 475 480
15. AL Folpe JR Goldblum BP Rubin, et al. 2005 Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases Am J Surg Pathol 29 1025 1033
16. A Llombart-Bosch G Contesso M Henry-Amar, et al. 1986 Histopathological predictive factors in Ewing's sarcoma of bone and clinicopathological correlations. A retrospective study of 261 cases Virchows Arch A Pathol Anat Histopathol 409 627 640
17. A Llombart-Bosch G Contesso A Peydro-Olaya 1996 Histology, immunohistochemistry, and electron microscopy of small round cell tumors of bone Semin Diagn Pathol 13 153 170 (Pubitemid 26282685)
18. EJ Fellinger P Garin-Chesa SL Su, et al. 1991 Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen Cancer Res 51 336 340
19. N Weidner J Tjoe 1994 Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma Am J Surg Pathol 18 486 494
20. SA CJ F Bertoni, et al. 1994 CD99 (p30/32MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience Appl Immunohistochem Mol Morphol 2 231 240
21. AM Dierick H Roels M Langlois 1993 The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis Pathol Res Pract 189 26 32
22. A Llombart-Bosch S Navarro 2001 Immunohistochemical detection of EWS and FLI-1 proteins in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression Appl Immunohistochem Mol Morphol 9 255 260
23. S Michels PE Swanson JA Robb, et al. 1987 Leu-7 in small cell neoplasms. An immunohistochemical study with ultrastructural correlations Cancer 60 2958 2964
24. M Miettinen J Chatten A Paetau, et al. 1998 Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors Am J Surg Pathol 22 327 332
25. AL Folpe CE Hill DM Parham, et al. 2000 Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing'ssarcoma/primitive neuroectodermal tumor Am J Surg Pathol 24 1657 1662
26. P Mhawech-Fauceglia F Herrmann R Penetrante, et al. 2006 Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies Histopathology 49 569 575
27. OM Tirado S Mateo-Lozano J Villar, et al. 2006 Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells Cancer Res 66 9937 9947
28. RS Bridge V Rajaram LP Dehner, et al. 2006 Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors Mod Pathol 19 1 8
29. O Delattre J Zucman T Melot, et al. 1994 The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts N Engl J Med 331 294 299
30. DC Mangham A Williams DJ McMullan, et al. 2006 Ewing's sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction Histopathology 48 363 376
31. VS Meier T Kuhne G Jundt, et al. 1998 Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations Diagn Mol Pathol 7 29 35
32. S Stegmaier I Leuschner E Aakcha-Rudel, et al. 2004 Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue-a report by the CWS-study group Klin Padiatr 216 315 322
33. AA Ahmed VE Nava T Pham, et al. 2006 Ewing sarcoma family of tumors in unusual sites: confirmation by rt-PCR Pediatr Dev Pathol 9 488 495
34. FG Barr J Chatten CM D'Cruz, et al. 1995 Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas JAMA 273 553 557
35. R Dagher TA Pham L Sorbara, et al. 2001 Molecular confirmation of Ewing sarcoma J Pediatr Hematol Oncol 23 221 224
36. PD Dhulipal 1997 Ets oncogene family Indian J Exp Biol 35 315 322
37. JR Downing DR Head DM Parham, et al. 1993 Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction Am J Pathol 143 1294 1300
38. A Lazar LV Abruzzo RE Pollock, et al. 2006 Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas Arch Pathol Lab Med 130 1199 1207
39. Machado I, Noguera R, Pellin A, López-Guerrero JA, Piqueras M, Navarro S, Llombart-Bosch A (2009) Molecular diagnosis of Ewing sarcoma family of tumors. A comparative analysis of 560 cases with FISH and RT-PCR. Diagn Mol Pathol (in press)
40. Arka T, Anderson PJ (1963) Histochemistry: theory, practice and bibliography. Harper & Row, Hoeber Medical Division, New York
41. A Llombart-Bosch A Pellin C Carda, et al. 2000 Soft tissue Ewing sarcoma-peripheral primitive neuroectodermal tumor with atypical clear cell pattern shows a new type of EWS-FEV fusion transcript Diagn Mol Pathol 9 137 144
42. ML Bernstein M Devidas D Lafreniere, et al. 2006 Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: pediatric oncology group/children's cancer group phase II study 9457-a report from the children's oncology group J Clin Oncol 24 152 159
43. DM Parham Y Hijazi SM Steinberg, et al. 1999 Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior Hum Pathol 30 911 918
44. M Paulussen B Frohlich H Jurgens 2001 Ewing tumour: incidence, prognosis and treatment options Paediatr Drugs 3 899 913
45. P Terrier M Henry-Amar TJ Triche, et al. 1995 Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis? Eur J Cancer 31A 307 314
46. ADA WL 1995 CD57: a review Appl Immunohistochem Mol Morphol 3 137 152
47. G Bacci S Ferrari F Bertoni, et al. 2000 Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli J Clin Oncol 18 4 11
48. JA Bridge ME Fidler JR Neff, et al. 1999 Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift Am J Surg Pathol 23 159 165
49. RL Carter SZ al-Sams RP Corbett, et al. 1990 A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children Histopathology 16 461 467
50. P Collini G Sampietro R Bertulli, et al. 2001 Cytokeratin immunoreactivity in 41 cases of ES/PNET confirmed by molecular diagnostic studies Am J Surg Pathol 25 273 274
51. E Davicioni DH Wai MJ Anderson 2008 Diagnostic and prognostic sarcoma signatures Mol Diagn Ther 12 359 374
52. DPS AF J Miser, et al. 1999 Pathology and prognosis in osseous Ewing's sarcoma-primitive neuroectodermal tumor (ES/PNET): preliminary data analysis from CCG 7881/POG 8850 Mod Pathol 12 2p
53. LJ Gardner JM Polski R Fallon, et al. 1998 Identification of CD56 and CD57 by flow cytometry in Ewing's sarcoma or primitive neuroectodermal tumor Virchows Arch 433 35 40
54. M Gu CR Antonescu G Guiter, et al. 2000 Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies Am J Surg Pathol 24 410 416
55. NA Jambhekar IN Bagwan P Ghule, et al. 2006 Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors Arch Pathol Lab Med 130 1813 1818
56. A Llombart-Bosch 1996 Small round cell tumors of bone and soft tissue. Introduction Semin Diagn Pathol 13 149 152
57. A Llombart-Bosch 1999 Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue Int J Surg Pathol 7 185 192
58. S Navarro P Giraudo AI Karseladze, et al. 2007 Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications Anticancer Res 27 2457 2463
59. U Yamaguchi T Hasegawa Y Morimoto, et al. 2005 A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue J Clin Pathol 58 1051 1056
60. JK Chan WY Tsang S Seneviratne, et al. 1995 The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors Am J Surg Pathol 19 1115 1123
61. P Ramani D Rampling M Link 1993 Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity Histopathology 23 557 561
62. MS Sandrin HA Vaughan MM Henning, et al. 1992 Expression cloning of cDNA clones encoding the human cell surface proteins HuLy-m6 and FMC29 Immunogenetics 35 283 285
63. ASM Llombart Bosch S Navarro P Baccini F Bertoni N Savelov JA Lopez-Guerrero 2007 Evaluation of CD99 expression in a large series of Ewing's sarcomas. The experience of the PROTHETS Group Lab Invest 87 18A
64. KE MP 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481
65. R Peto J Peto 1987 Asymptomatically efficient rank invariant test procedures J R Stat Soc 135 185 206
66. D Cox 1972 Regression models and life tables J R Stat Soc 34 187 220
67. G Contesso A Llombart-Bosch P Terrier, et al. 1992 Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? An analysis of 30 cases with immunohistochemical and electron-microscopic support treated at the Institute Gustave Roussy Cancer 69 1012 1020
68. AA Renshaw AR Perez-Atayde JA Fletcher, et al. 1996 Cytology of typical and atypical Ewing's sarcoma/PNET Am J Clin Pathol 106 620 624
69. P Terrier A Llombart-Bosch G Contesso 1996 Small round blue cell tumors in bone: prognostic factors correlated to Ewing's sarcoma and neuroectodermal tumors Semin Diagn Pathol 13 250 257
70. KR Hartman TJ Triche TJ Kinsella, et al. 1991 Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors Cancer 67 163 171
71. G Bacci S Ferrari F Bertoni, et al. 2000 Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the Istituto Rizzoli J Clin Oncol 18 885 892
72. G Bacci S Ferrari A Comandone, et al. 2000 Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years Acta Oncol 39 111 116
73. R Luksch G Sampietro P Collini, et al. 1999 Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in children Tumori 85 101 107
74. LH Wexler WH Meyer DM Parham, et al. 2000 Neural differentiation and prognosis in peripheral primitive neuroectodermal tumor J Clin Oncol 18 2187 2188
75. LC Kang CH Dunphy 2006 Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes Arch Pathol Lab Med 130 153 157
76. K Scotlandi M Serra MC Manara, et al. 1996 Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor Hum Pathol 27 408 416
77. G Nilsson M Wang J Wejde, et al. 1999 Detection of EWS/FLI-1 by immunostaining. An adjunctive tool in diagnosis of Ewing's sarcoma and primitive neuroectodermal tumour on cytological samples and paraffin-embedded archival material Sarcoma 3 25 32
78. S Rossi E Orvieto A Furlanetto, et al. 2004 Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody Mod Pathol 17 547 552
79. JD Khoury 2008 Ewing sarcoma family of tumors: a model for the new era of integrated laboratory diagnostics Expert Rev Mol Diagn 8 97 105
80. SH Olsen DG Thomas DR Lucas 2006 Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma Mod Pathol 19 659 668
81. AP Makrigiannis P Parham 2008 The evolution of NK cell diversity Semin Immunol 20 309 310
82. P Parham 2008 The genetic and evolutionary balances in human NK cell receptor diversity Semin Immunol 20 311 316
83. E de Alava A Kawai JH Healey, et al. 1998 EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma J Clin Oncol 16 1248 1255
84. M Drab P Verkade M Elger, et al. 2001 Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice Science 293 2449 2452
85. Z Lu S Ghosh Z Wang, et al. 2003 Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion Cancer Cell 4 499 515
86. TM Williams MP Lisanti 2005 Caveolin-1 in oncogenic transformation, cancer, and metastasis Am J Physiol Cell Physiol 288 C494 C506
87. K Baird S Davis CR Antonescu, et al. 2005 Gene expression profiling of human sarcomas: insights into sarcoma biology Cancer Res 65 9226 9235
88. T Ando H Ishiguro M Kimura, et al. 2007 The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma Oncol Rep 18 601 609
89. MM Belanger E Roussel J Couet 2004 Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene Chest 125 106S
90. T Bouras MP Lisanti RG Pestell 2004 Caveolin-1 in breast cancer Cancer Biol Ther 3 931 941
91. L Campbell B Jasani K Edwards, et al. 2008 Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma Br J Cancer 98 931 940
92. L Cantiani MC Manara C Zucchini, et al. 2007 Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling Cancer Res 67 7675 7685
93. B Davidson I Goldberg V Givant-Horwitz, et al. 2002 Caveolin-1 expression in ovarian carcinoma is MDR1 independent Am J Clin Pathol 117 225 234
94. B Davidson JM Nesland I Goldberg, et al. 2001 Caveolin-1 expression in advanced-stage ovarian carcinoma-a clinicopathologic study Gynecol Oncol 81 166 171
95. E Garcia M Li 2006 Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma Am J Clin Pathol 125 392 398
96. Y Ito H Yoshida C Tomoda, et al. 2005 Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma Pathol Res Pract 201 545 549
97. I Mercier KG Bryant F Sotgia, et al. 2009 Using caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the caveolin-1 (P132L) mutation Cell Cycle 8 1396 1401
98. C Racine M Belanger H Hirabayashi, et al. 1999 Reduction of caveolin 1 gene expression in lung carcinoma cell lines Biochem Biophys Res Commun 255 580 586